WO2023181075 - AMORPHOUS SOLID DISPERSIONS OF DEUCRAVACITINIB AND PROCESSES FOR THE PREPARATION THEREOF
National phase entry is expected:
Publication Number
WO/2023/181075
Publication Date
28.09.2023
International Application No.
PCT/IN2023/050280
International Filing Date
23.03.2023
Title **
[English]
AMORPHOUS SOLID DISPERSIONS OF DEUCRAVACITINIB AND PROCESSES FOR THE PREPARATION THEREOF
[French]
DISPERSIONS SOLIDES AMORPHES DE DEUCRAVACITINIB ET LEURS PROCÉDÉS DE PRÉPARATION
Applicants **
DR. REDDY'S LABORATORIES LIMITED
Inventors
PATHIVADA, Deepika
ARIGE, Ashok
SEN, Saikat
ORUGANTI, Srinivas
BUDHDEV, Rajeev Rehani
KOTTUR, Mohan Kumar
SAMPATH, Magesh
Priority Data
202241016761
24.03.2022
IN
202241030322
26.05.2022
IN
202241042926
27.07.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2127 | |
| EPO | Filing, Examination, Granting | 11796 | |
| Japan | Filing, Examination, Granting | 2104 | |
| South Korea | Filing, Examination, Granting | 1970 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
23,937
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present application relates to amorphous solid dispersions of Deucravacitinib, process for the preparation of amorphous solid dispersion of Deucravacitinib, process for the preparation crystalline form of Deucravacitinib and process for the preparation of stable premix of amorphous solid dispersion of Deucravacitinib together with at least one pharmaceutically acceptable polymer matrix and syloid.[French]
La présente invention concerne des dispersions solides amorphes de deucravacitinib, un procédé pour la préparation d'une dispersion solide amorphe de deucravacitinib, un procédé de préparation de la forme cristalline de deucravacitinib et un procédé pour la préparation d'un prémélange stable de dispersion solide amorphe de deucravacitinib conjointement avec au moins une matrice polymère pharmaceutiquement acceptable et un syloïde.